Commissioners told to slash hospital spend on high-cost drugs

GP commissioners must urgently bring 'accelerating' hospital spend on high-cost drugs under control, the DH has warned.

Spending: GP commissioners urged to cut hospital drug costs
Spending: GP commissioners urged to cut hospital drug costs

The department said the NHS may be wasting millions of pounds a year because hospitals and providers are not incentivised to cut the cost of drugs that fall outside of the Payment by Results tariff.

Ministers want GP commissioners to work with hospitals to reduce the bill for high-cost ‘homecare’ treatments, which now cost the NHS at least £1.25bn. This figure is rising by 20% per year.

But last year University Hospital Southampton NHS Foundation Trust saved around £4m by reviewing its homecare spending, suggesting similar efforts across the NHS could save hundreds of millions of pounds.

Homecare treatments are hospital-prescribed medicines supplied directly to patients’ homes. Prices are negotiated locally because they fall outside of the national Payment by Results tariff.

But a DH report produced as part of the NHS efficiency savings drive suggested the NHS may be wasting money ‘paying for more expensive treatments where equally effective but cheaper alternatives are available’. It said this may be due to the lack of a financial incentive for commissioners and providers to reduce treatment costs.

The DH has appointed Mark Hackett, chief executive of University Hospital Southampton and author of a 2011 report into homecare medicines, to lead a project aiming ‘to maximise efficiency and value for NHS budgets’ relating to homecare treatments.

In a letter to hospital chiefs, he warned that these costs are set to accelerate unless the NHS takes action.

He added: ‘We will be seeking to engage with clinical commissioning groups (CCGs) to ensure that these efficiencies are maximised in 2013/14.’

The DH says the report will help commissioners and providers when ensuring patients can access NICE-approved treatments under the NHS Constitution.

Earlier this year a GP magazine investigation found the NHS may fail to hit efficiency targets because hospitals' efforts to control drug spending are decades behind those in primary care.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Practices handed one-month opt-out window as revamped network DES unveiled

Practices handed one-month opt-out window as revamped network DES unveiled

NHS England has unveiled a revamped DES package for 2020/21 confirming new targets,...

GPs delivered huge rise in face-to-face consultations in week before NHS England letter

GPs delivered huge rise in face-to-face consultations in week before NHS England letter

GPs delivered a huge increase in face-to-face appointments in the week before NHS...

RCGP facing legal action over stance on assisted dying

RCGP facing legal action over stance on assisted dying

The RCGP is facing legal action over its decision to remain opposed to assisted dying...

Medeconomics Live aims to help practices thrive under the new GP contract

Medeconomics Live aims to help practices thrive under the new GP contract

The one-day, virtual Medeconomics Live conference aims to provide practices with...

GPs face wave of abuse and complaints after NHS England face-to-face appointments claims

GPs face wave of abuse and complaints after NHS England face-to-face appointments claims

GP practices have faced a wave of abuse and complaints after a letter from NHS England...

Government denies plan to make GPs 'gatekeepers' of COVID-19 testing

Government denies plan to make GPs 'gatekeepers' of COVID-19 testing

The government has denied plans to make GPs 'gatekeepers' of the struggling COVID-19...